Expand ZBIO Menu
ZBIO MENU

ZBIO Stock Posts


ZBIO #ZenasBiopharma stock declines -14.0% in premarket,

Premarket Decliner

ZBIO Zenas Biopharma22.16-0.03-0.1%

Premarket:19.05-3.11 (-14.0%)

Zenas BioPharma Announces Pricing of Concurrent Public Offerings of 2.50% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $300.0 Million

Globe NewswireFri, 27-Mar 12:12 AM
Unusual Option Volume

ZBIO Zenas Biopharma18.94+2.86 (+17.8%)

Zenas Biopharma trades 2,488 contracts.
View Details...
Unusual Option Volume

ZBIO Zenas Biopharma14.63-19.87 (-57.6%)

Zenas Biopharma trades 2,200 contracts. The company has the following event: Conference Call and Webcast to Discuss Positive Results from Phase 3 INDIGO Trial of Obexelimab in IgG4-RD on Jan 5, 2026. News: SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Zenas BioPharma, Inc. (NASDAQ: ZBIO)
View Details...
ZBIO #ZenasBiopharma stock declines -56.7% in premarket,

Premarket Decliner

ZBIO Zenas Biopharma34.50-1.81-5.0%

Premarket:14.95-19.55 (-56.7%)

Zenas BioPharma Announces Positive Results from Phase 3 INDIGO Registrational Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD)

Globe NewswireMon, 5-Jan 7:05 AM
Unusual Option Volume

ZBIO Zenas Biopharma36.33+1.26 (+3.6%)

Zenas Biopharma trades 2,333 contracts. The highest volume is in the 15-May-26 20 puts.
View Details...
Load Earlier Posts
Market Data Delayed 15 Minutes